DK0890362T3 - Præparater, som er nyttige til overførsel af terapeutisk ktive polynukleotider til en målcelle, og anvendelse heraf i genterapi - Google Patents

Præparater, som er nyttige til overførsel af terapeutisk ktive polynukleotider til en målcelle, og anvendelse heraf i genterapi

Info

Publication number
DK0890362T3
DK0890362T3 DK98112151T DK98112151T DK0890362T3 DK 0890362 T3 DK0890362 T3 DK 0890362T3 DK 98112151 T DK98112151 T DK 98112151T DK 98112151 T DK98112151 T DK 98112151T DK 0890362 T3 DK0890362 T3 DK 0890362T3
Authority
DK
Denmark
Prior art keywords
therapeutically active
target cell
gene therapy
transfer
compositions useful
Prior art date
Application number
DK98112151T
Other languages
Danish (da)
English (en)
Inventor
Rainer Bischoff
Hanno Kolbe
Klaus Schughart
Original Assignee
Transgene Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene Sa filed Critical Transgene Sa
Application granted granted Critical
Publication of DK0890362T3 publication Critical patent/DK0890362T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98112151T 1997-07-01 1998-07-01 Præparater, som er nyttige til overførsel af terapeutisk ktive polynukleotider til en målcelle, og anvendelse heraf i genterapi DK0890362T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9708267 1997-07-01
FR9712950 1997-10-16

Publications (1)

Publication Number Publication Date
DK0890362T3 true DK0890362T3 (da) 2001-06-11

Family

ID=26233650

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98112151T DK0890362T3 (da) 1997-07-01 1998-07-01 Præparater, som er nyttige til overførsel af terapeutisk ktive polynukleotider til en målcelle, og anvendelse heraf i genterapi

Country Status (12)

Country Link
US (1) US6656734B1 (fr)
EP (1) EP0890362B1 (fr)
JP (1) JP3499137B2 (fr)
CN (1) CN1212890A (fr)
AT (1) ATE200226T1 (fr)
AU (1) AU707186B2 (fr)
CA (1) CA2242035C (fr)
DE (1) DE69800659T2 (fr)
DK (1) DK0890362T3 (fr)
ES (1) ES2156421T3 (fr)
GR (1) GR3035797T3 (fr)
PT (1) PT890362E (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1006197A1 (fr) * 1998-12-04 2000-06-07 Transgene S.A. L'utilisation d'un complexe immunologique pour la préparation d'une composition thérapeutique, utile pour la transfection des polynucléotides dans des cellules macropinocyte
EP1013772A1 (fr) * 1998-12-21 2000-06-28 Transgene S.A. Procédé de préparation d'une suspension stable de posiplexes
EP1173217B1 (fr) * 1999-05-05 2005-10-19 Merrion Research I Limited Apport ameliore de medicaments a base d'acide nucleique
DE19933506A1 (de) * 1999-07-16 2001-01-25 Deutsches Krebsforsch Zelluläre Aufnahme von DNA
CA2388337C (fr) * 1999-10-22 2013-01-08 Aventis Pasteur Limited Procede visant a provoquer et/ou stimuler une reponse immunitaire aux antigenes tumoraux
DK1282702T3 (da) 2000-05-10 2007-04-02 Sanofi Pasteur Ltd Immunogene polypeptider, som er kodet af KAGE-minigener, og anvendelser deraf
EP1556082A1 (fr) * 2002-10-22 2005-07-27 Aventis Pasteur Limited Vaccins anticancereux et cytokines a haute dose utilisees comme adjuvants
ATE500267T1 (de) 2003-07-21 2011-03-15 Transgene Sa Multifunktionelle cytokine
HUE056941T2 (hu) 2004-12-22 2022-04-28 Nitto Denko Corp Gyógyszerhordozó és gyógyszerhordozó kit fibrózis gátlására
US20120269886A1 (en) 2004-12-22 2012-10-25 Nitto Denko Corporation Therapeutic agent for pulmonary fibrosis
US9572886B2 (en) 2005-12-22 2017-02-21 Nitto Denko Corporation Agent for treating myelofibrosis
TWI407971B (zh) 2007-03-30 2013-09-11 日東電工股份有限公司 Cancer cells and tumor-related fibroblasts
US8357531B2 (en) 2007-07-03 2013-01-22 Transgene S.A. Immortalized avian cell lines
CN101970012A (zh) 2007-09-14 2011-02-09 日东电工株式会社 药物载体
JP5588970B2 (ja) * 2008-05-27 2014-09-10 ダコ・デンマーク・エー／エス ハイブリダイゼーション組成物及び方法
US9303287B2 (en) 2009-02-26 2016-04-05 Dako Denmark A/S Compositions and methods for RNA hybridization applications
EP2507391B1 (fr) * 2009-12-02 2016-08-17 Dako Denmark A/S Compositions et procédés pour réaliser des hybridations sans dénaturation
CA2795050C (fr) 2010-03-31 2018-05-22 Stabilitech Ltd. Procede de conservation d'adjuvants d'alun et de vaccins contenant un adjuvant d'alun
WO2011121301A1 (fr) 2010-03-31 2011-10-06 Stabilitech Ltd Excipients pour la stabilisation de particules virales, de polypeptides ou de matériels biologiques
ES2757591T3 (es) 2010-03-31 2020-04-29 Stabilitech Biopharma Ltd Estabilización de partículas virales
US10662465B2 (en) 2011-09-30 2020-05-26 Agilent Technologies, Inc. Hybridization compositions and methods using formamide
GB201117233D0 (en) 2011-10-05 2011-11-16 Stabilitech Ltd Stabilisation of polypeptides
US11118226B2 (en) 2011-10-21 2021-09-14 Agilent Technologies, Inc. Hybridization compositions and methods
EP3587455A1 (fr) 2012-10-23 2020-01-01 Emory University Conjugués de gm-csf et d'il-4, compositions et procédés associés
GB201406569D0 (en) 2014-04-11 2014-05-28 Stabilitech Ltd Vaccine compositions
US11826423B2 (en) 2016-11-16 2023-11-28 Immunomic Therapeutics, Inc. Nucleic acids for treatment of allergies
IL270024B2 (en) 2017-04-22 2025-04-01 Immunomic Therapeutics Inc LAMP structures and their use in vaccination
KR20200016224A (ko) 2017-05-02 2020-02-14 이뮤노믹 쎄라퓨틱스, 인크. 암 항원을 포함하는 lamp (리소솜 연관 막 단백질) 구축물
GB2562241B (en) 2017-05-08 2022-04-06 Stabilitech Biopharma Ltd Vaccine compositions
EP3793595A1 (fr) 2018-05-15 2021-03-24 Immunomic Therapeutics, Inc. Constructions améliorées de lamp comprenant des allergènes
WO2020061528A1 (fr) 2018-09-21 2020-03-26 University Of Connecticut Compositions et procédés pour restaurer l'expression du gène ube3a paternel dans le syndrome d'angelman humain
JP2022551732A (ja) 2019-10-18 2022-12-13 イミュノミック セラピューティックス， インコーポレイテッド がん抗原を含む改良ｌａｍｐ構築物
EP4508071A1 (fr) 2022-04-10 2025-02-19 Immunomic Therapeutics, Inc. Constructions de lamp bicistroniques comprenant des gènes améliorant la réponse immunitaire et leurs procédés d'utilisation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
JPS61139387A (ja) * 1984-12-11 1986-06-26 Nakano Vinegar Co Ltd グルコノバクタ−属酢酸菌の形質転換方法
US6048729A (en) * 1987-05-01 2000-04-11 Transkaryotic Therapies, Inc. In vivo protein production and delivery system for gene therapy
DE3911765A1 (de) 1989-04-11 1990-10-18 Zinser Textilmaschinen Gmbh Vorgarnspulenwechselwagen
US5028726A (en) * 1990-02-07 1991-07-02 The University Of Vermont And State Agricultural College Platinum amine sulfoxide complexes
FR2701953B1 (fr) 1993-02-22 1995-05-24 Centre Nat Rech Scient Protéine de fusion multi-VIP et procédé de préparation de VIP recombinant.
IL112920A (en) * 1994-03-07 2003-04-10 Dow Chemical Co Composition comprising a dendritic polymer complexed with at least one unit of biological response modifier and a process for the preparation thereof
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5525711A (en) 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
US5650135A (en) 1994-07-01 1997-07-22 The Board Of Trustees Of The Leland Stanford Junior University Non-invasive localization of a light-emitting conjugate in a mammal
US6040295A (en) * 1995-01-13 2000-03-21 Genemedicine, Inc. Formulated nucleic acid compositions and methods of administering the same for gene therapy
CA2225460A1 (fr) 1995-06-23 1997-01-09 Winston Campbell Patterson Regulation de la transcription de genes codant des recepteurs du facteur de croissance endotheliale vasculaire
AUPN741696A0 (en) * 1996-01-05 1996-01-25 Commonwealth Scientific And Industrial Research Organisation Delivery of nucleic acids ii

Also Published As

Publication number Publication date
ATE200226T1 (de) 2001-04-15
CA2242035A1 (fr) 1999-01-01
GR3035797T3 (en) 2001-07-31
DE69800659T2 (de) 2001-10-18
ES2156421T3 (es) 2001-06-16
JPH11106355A (ja) 1999-04-20
PT890362E (pt) 2001-09-28
AU707186B2 (en) 1999-07-01
EP0890362A1 (fr) 1999-01-13
CA2242035C (fr) 2004-11-23
AU7394298A (en) 1999-01-28
JP3499137B2 (ja) 2004-02-23
CN1212890A (zh) 1999-04-07
US6656734B1 (en) 2003-12-02
EP0890362B1 (fr) 2001-04-04
DE69800659D1 (de) 2001-05-10

Similar Documents

Publication Publication Date Title
DK0890362T3 (da) Præparater, som er nyttige til overførsel af terapeutisk ktive polynukleotider til en målcelle, og anvendelse heraf i genterapi
Curry et al. Calcium uptake by sarcoplasmic reticulum of muscle from vitamin D-deficient rabbits
GB2037745B (en) Diphenylbutyl - piperazinecarboxamides
YU29099A (sh) Derivati 2-(purin-9-il)-tetrahidrofuran-3,4-diola
AP2000001881A0 (en) 2-(Purine-9-YL)-tetrahydrofuran-3,4 4-diol derivatives.
WO1999038877A3 (fr) Derives de 2-(purine-9-yl)-tetrahydrofurane-3,4-diol
ATE248837T1 (de) Chinuclidin-acrylamide
BR9507506A (pt) Processo para exterminar uma célula processo para tratamento de càncer composição e kit terapéutico
WO2000078779A3 (fr) Agonistes du recepteur a2a n-pyrazole
HK1038744A1 (zh) 用於治療炎性疾病的化合物
DE3267039D1 (en) Stable s-adenosylmethionine salts, the process for their preparation and therapeutic compositions which contain them as active principle
BRPI0117180B8 (pt) composição farmacêutica em uma forma de unidade sólida de dosagem para a administração oral a um ser humano ou animal inferior
BR9714063A (pt) Composto, processo para a preparação e uso do mesmo, composição farmacêutica, e, processos para preparação da mesma, para executar a imunossupressão e para tratar ou reduzir o risco de uma doença reversìvel, obstrutiva das vias aéreas
HK1041824B (zh) 治療系統
ATE49970T1 (de) Neue pyrrolo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
WO2000078776A3 (fr) Agonistes du recepteur a2a a base de thiophene
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
EA200500661A1 (ru) Катионный аналог кардиолипина (варианты), его применение (варианты), композиция и набор для трансфекции клеток (варианты)
SE9903611D0 (sv) Novel compounds III
IE892094L (en) New strontium salt, process for the preparation thereof and¹pharmaceutical compositions containing it
DK1332764T3 (da) Mucoadhæsivt, termoresponsivt lægemiddel-bærer-præparat
ATE6643T1 (de) Neue 3,4-diaza-bicyclo(4.1.0)hepten-(2)-one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel.
IL67686A (en) 3-(1h-tetrazol-5-yl)-4(3h)-quinazolinones,their preparation and pharmaceutical compositions containing them
DE3665861D1 (en) Basically substituted phenylacetaldehydes, their preparation and therapeutic compositions containing them